Markets:

Overview

News

Currencies

International

Treasuries

Sana Biotechnology, Inc. - Common Stock (NQ:SANA)

3.980 -0.140 (-3.40%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sana Biotechnology, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA

March 26, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA

March 26, 2025

From Pomerantz LLP

Via GlobeNewswire

Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

March 24, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs ↗

January 10, 2025

Via Benzinga

SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 23, 2025

From The Schall Law Firm

Via Business Wire

Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

March 17, 2025

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference

February 24, 2025

From Sana Biotechnology, Inc

Via GlobeNewswire

Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why ↗

January 31, 2025

Biotech remains a high-risk, high-reward sector, and this month’s top draws reflect retail’s appetite for stocks with major clinical and regulatory catalysts.

Via Stocktwits

There May Still Be Time to Get in on These 3 Trending Biotechs

January 20, 2025

Biotech firms as a group declined slightly in the last year amid a tough external environment, but these three companies could grow in 2025.

Via MarketBeat

Topics ETFs Economy

Biotech Breakthroughs: Sana Biotechnology (NASDAQ: SANA) Type 1 Diabetes, CS Diagnostics (OTCQB: CSDX) Cancer Therapy – CURR, TPET, PRSO, PNPN.V, EONR – Plus More Stocks Under $2 Inside See Now!

January 08, 2025

Via AB Newswire

Topics Artificial Intelligence

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 08, 2025

Via Benzinga

Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 08, 2025

From Sana Biotechnology, Inc

Via GlobeNewswire

Crude Oil Down 1%; US Weekly Jobless Claims Decline ↗

January 08, 2025

Via Benzinga

AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday ↗

January 08, 2025

Via Benzinga

US Stocks Down; Acuity Brands Posts Weak Revenue ↗

January 08, 2025

Via Benzinga

Sana Biotechnology Stock Surges Over 200% On Wednesday - Here's Why ↗

January 08, 2025

Sana Biotechnology's first-in-human study shows UP421 pancreatic islet cells surviving and functioning in type 1 diabetes without immunosuppression.

Via Benzinga

Why Cal-Maine Foods Shares Are Trading Higher By 4%; Here Are 20 Stocks Moving Premarket ↗

January 08, 2025

Via Benzinga

Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

January 07, 2025

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus

December 02, 2024

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at December 2024 Investor Conferences

November 25, 2024

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates

November 08, 2024

From Sana Biotechnology, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 05, 2024

Via Benzinga

This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

November 05, 2024

Via Benzinga

Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025

November 04, 2024

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference

September 30, 2024

From Sana Biotechnology, Inc

Via GlobeNewswire

Casella Waste Systems, SES AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

September 18, 2024

Via Benzinga

Topics Artificial Intelligence

Sana Biotechnology to Present at September 2024 Investor Conferences

August 29, 2024

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer

August 26, 2024

From Sana Biotechnology, Inc

Via GlobeNewswire

SANA Stock Earnings: Sana Biotechnology Misses EPS for Q2 2024 ↗

August 09, 2024

SANA stock results show that Sana Biotechnology missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates

August 08, 2024

From Sana Biotechnology, Inc

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.